preview

Hospital Care

Decent Essays

Healthcare costs in the U.S. reached an astonishing $3.4 trillion dollars in 2016, with the per capita expenditure surpassing $10,000 (CMS.gov). At 17.8% of the Gross Domestic Product in 2017, total national health expenditures are projected to reach 19.9% by 2025 (CMS.gov). These numbers are steadily increasing year after year however, their true origins are unknown. Nonetheless, the rapid growth in healthcare spending is driven by several contributing factors including; an increase in prescription drug spending, hospital care, physician and clinical services, advancements in medical technology, and private insurer administrative costs and overhead. This paper will delve into several of the potential culprits as well as the associated …show more content…

Currently, hospitals are facing considerable workforce shortages of pharmacists, certified aides and medical assistants, registered nurses, and allied health professionals. Vacancies and turnover rates are high for registered and licensed practical nurses, for example, predominately due to an increasing number of students seeking administrative careers or employment with non-hospital competitors. During a period of rising service demand, continued clinician scarcity will likely put additional cost pressures on hospitals, while further increasing the overall spending growth.
Pharmaceuticals
In 2017, $324.6 billion was spent on retail prescription drugs which amounts to a 10% share of overall healthcare spending (CMS.gov). Although spending growth on prescription drugs slowed slightly in 2015, this sector still outpaced spending in all other services (CMS.gov). According to research conducted by Pfizer, Inc., prescription drugs have accounted for ten cents of every dollar spent on health care since 2004. Pharmaceutical spending is projected to continue at this rate over the next several years, and even increase, but why? (Pfizer, Inc., “Role of Pharmaceuticals in U.S. Health Care Spending,” 2015). Firstly, pharmaceutical spending is an umbrella term that encompasses price growth for already expensive brand-name drugs, increased spending on generics and new medications,

Get Access